华领医药-B（02552.HK）今日盘中大涨5.88%，股价一度触及3.92港元，引发市场关注。该公司近期公布的中期业绩显示，其商业化转型取得显著成效，首次实现半年度盈利。
根据公司财报，华领医药上半年实现净利润11.839亿元，这是公司首次在业绩期内盈利。其主要产品华堂宁销量达176.4万盒，同比增长108%，净销售额2.174亿元，同比增长112%。值得注意的是，公司毛利率升至54.2%，较去年同期增长7.7个百分点，显示出生产规模扩大和运营效率提升带来的积极影响。
华领医药自2025年1月全面接管华堂宁商业化运营后，凭借自主销售团队实现了显著增长。医保覆盖的持续扩大也助力公司在二级和三级医院的处方量大幅增加。此外，公司正积极拓展海外业务，加速全球化布局，并持续加强研发力度，为未来发展奠定基础。这些因素共同推动了投资者信心，促使股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.